New Issue: Oragenics sells $2.5 million of common stock through private placement

By Devika Patel

Knoxville, Tenn., Jan. 5 - Oragenics, Inc. said it completed a $2.5 million private placement of stock. The company received $2.45 million in cash at closing and $54,062.50 through the cancellation of the same dollar amount of outstanding debt.

The company sold 10,016,250 common shares at $0.25 apiece. Approximately half of the total investment, or $1.25 million, was made by the Koski Family LP.

Proceeds will be used for development of the company's DPOLT synthetic chemistry platform.

Oragenics is an Alachu, Fla.-based biopharmaceutical company.

Issuer:	Oragenics, Inc.
Issue:	Common stock
Amount:	$2,504,063
Shares:	10,016,250
Price:	$0.25
Warrants:	No
Investor:	Koski Family LP (for $1.25 million)
Settlement date:	Jan. 5
Stock symbol:	Amex: ONI
Stock price:	$0.35 at close Jan. 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.